Peripartum cardiomyopathy: A comprehensive review

International Journal of Cardiology

Volumn 118, Issue 3, 2007, Pages 295-303

  Abboud, John ^a   Murad, Yahya ^a   Chen Scarabelli, Carol ^b   Saravolatz, Louis ^a   Scarabelli, Tiziano M ^a  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; Etiology; Peripartum cardiomyopathy; Risk factors; Treatment

Indexed keywords

AMLODIPINE; CARVEDILOL; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; IMMUNOGLOBULIN; METOPROLOL; MILRINONE; NITRATE; NITROPRUSSIDE SODIUM; WARFARIN;

ADD ON THERAPY; AEROBIC EXERCISE; APOPTOSIS; AUTOIMMUNITY; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CULTURAL ANTHROPOLOGY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MYOCARDITIS; NONHUMAN; NUTRITIONAL DEFICIENCY; PERIPARTUM CARDIOMYOPATHY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SODIUM RESTRICTION; THROMBOEMBOLISM;

ADULT; CARDIOMYOPATHY, DILATED; CARDIOTONIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROGNOSIS; PUERPERAL DISORDERS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34247846210     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.08.005     Document Type: Review

References (144)

1. Virchow, R. Sitzing der Berliner Geburtshilflisher Gersellskhalt, cited by Porak, C. De l'influence réciproque de la grossesse et des maladies du Coeur, thesis, Paris, 1880.
2. Ritchie C. Clinical contribution to the patho-diagnosis and treatment of certain chronic diseases of the heart. Edinburgh Med J 2:2 (1850)
3. Porak, C. De l'influence réciproque de la grossesse et des maladies du Coeur, thesis, Paris, 1880.
4. Veille J.C. Peripartum cardiomyopathies: a review. Am J Obstet Gynecol 148 (1984) 805-818
5. Gouley B.A., McMillan T.M., and bellet S. Idiopathic myocardial degeneration associated with pregnancy and especially the puerperium. Am J Med Sci 19 (1937) 185-199
6. Hull E., and Hidden E. Postpartal heart failure. South Med J 31 (1938) 265-270
7. Sakakibara S., Sekiguchi M., Konno S., and Kusumoto M. Idiopathic postpartum cardiomyopathy: report of a case with special reference to its ultrastructural changes in the myocardium as studies by endomyocardial biopsy. Am Heart J 80 (1970) 385-395
8. Manolio T.A., Baughman K.L., Rodeheffer R., et al. Prevalence and etiology of idiopathic cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop). Am J Cardiol 69 (1992) 1458-1466
9. Julian D.G., and Szekely P. Peripartum cardiomyopathy. Prog Cardiovasc Dis 27 (1985) 223-240
10. Danbauchi S.S. Echocardiographic features of peripartum cardiac failure: the Zaria syndrome. Trop Doct 32 (2002) 24-27
11. Demakis J.G., Rahimtoola S.H., Sutton G.C., et al. Natural course of peripartum cardiomyopathy. Circulation 44 (1971) 1053-1061
12. Pearson G.D., Veille J.C., Rahimtoola S., et al. Peripartum cardiomyopathy. National Heart Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283 (2000) 1183-1188
13. Hibbard J.U., Lindheimer M., and Lang R.M. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol 94 (1999) 311-316
14. Chapa J.B., Heiberger H.B., Weinert L., Decara J., Lang R.M., and Hibbard J.U. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol 105 (2005) 1303-1308
15. Witlin A.G., Mabie W.C., and Sibai B.M. Peripartum cardiomyopathy: a longitudinal echocardiographic study. Am J Obstet Gynecol 177 (1997) 1129-1132
16. Brown G., O'Leary M., Douglas I., and Herkes R. Perioperative management of a case of severe peripartum cardiomyopathy. Anaesth Intensive Care 20 (1992) 80-83
17. Forssell G., Laska J., Olofsson C., Olsson M., and Mogensen L. Peripartum cardiomyopathy: three cases. J Intern Med 235 (1994) 493-496
18. Yahagi N., Kumon K., and Nakatani T. Peripartum cardiomyopathy and tachycardia followed by multiple organ failure. Anesth Analg 79 (1994) 581-582
19. Rizeq M.N., Rickenbacher P.R., Fowler M.B., and Billingham M.E. Incidence of myocarditis in peripartum cardiomyopathy. Am J Cardiol 74 (1994) 474-477
20. Mellor D.J., and Bodenham A. Infiltration anesthesia in the management of caesarian section in a patient with peripartum cardiomyopathy. Med Trop 56 (1996) 376-380
21. Alvarez Navascues R., Marin R., Testa A., Paneda F., and Alvarez Grande J. Preeclampsia and peripartum cardiomyopathy: infrequent association. Nefrologia 21 (2001) 84-87
22. Elkayam U., Akhter M.W., Singh H., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111 (2005) 2050-2055
23. Cunningham F.G., Pritchard J.A., Hankins G.D., Anderson P.L., Lucas M.J., and Armstrong K.F. Peripartum heart failure: Idiopathic cardiomyopathy or compounding cardiovascular events. Obstet Gynecol 67 (1986) 157-168
24. Cetta F., and michels V.V. The natural history and spectrum of idiopathic dilated cardiomyopathy, including HIV and peripartum cardiomyopathy. Curr Opin Cardiol 10 (1995) 332-338
25. Homans D.C. Peripartum cardiomyopathy. N Engl J Med 312 (1985) 1432
26. Fett J.D., Carraway R.D., Dowell D.L., King M.E., and Pierre R. Peripartum cardiomyopathy in the Hospital Albert Schweitzer District of Haiti. Am J Obstet Gynecol 186 (2002) 1005-1010
27. Fett J.D., Christie L.G., Carraway R.D., Sundstrom J.B., and Ansari A.A. Learning from a population-based peripartum cardiomyopathy registry. Circulation 110 III (2004) 727
28. Fett J.D., Dowell D.L., Carraway R.D., Sundstrom J.B., and Ansari A.A. One hundred cases of peripartum cardiomyopathy... and counting: what is going on?. Int J Cardiol 97 (2004) 571-573
29. Ferriere M., Sacrez A., Bouhour J.B., et al. La myocardiopathie du peripartum: aspects actuels. Etude multicentrique: 11 observations. Arch Mal Coeur 83 (1990) 1563-1569
30. Cénac A., and Djibo A. Postpartum cardiac failure in Sudanese-Sahelian Africa: clinical prevalence in western Niger. Am J Trop Med Hyg 58 (1998) 319-323
31. Davidson N.M., and Parry E.H. Peri-partum cardiac failure. Q J Med 47 (1978) 431-461
32. Sanderson J.E., Adesanya C.O., Anjorin F.I., and Parry E.H. Postpartum cardiac failure-heart failure due to volume overload?. Am Heart J 97 (1979) 613
33. Fillmore S.J., and Parry E.H. The evolution of peripartal heart failure in Zaria. Circulation 56 (1977) 1058
34. Lang R.M., Lampert M.B., Poppas A., et al. In: Elkayam U., and Gleicher N. (Eds). Cardiac problem in pregnancy: diagnosis and management of maternal and fetal disease. 3rd Ed. (1998), Wiley-Liss, New York 87
35. Witlin A.G., Mabie W.C., and Sibai B.M. Peripartum cardiomyopathy: an ominous diagnosis. Am J Obstet Gynecol 176 (1997) 182-188
36. Desai D., Moodley J., and Naidoo D. Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 25 (1995) 118-123
37. Heider A.L., Kuller J.A., Strauss R.A., and Wells S.R. Peripartum cardiomyopathy: a review of the literature. Obstet Gynecol Surv 54 (1999) 526-531
38. O'Connell J.B., Costanzo-Nordin M.R., Subramanian R., et al. Peripartum cardiomyopathy: clinical, hemodynamic, histologic, and prognostic characteristics. J Am Coll Cardiol 8 (1986) 52-56
39. Lampert M.B., Hibbard J., Weinert L., Briller J., Lindheimer M., and Lang R.M. Peripartum heart failure associated with prolonged tocolytic therapy. Am J Obstet Gynecol 168 (1993) 493-495
40. Lampert M.B., and Lang R.M. Peripartum cardiomyopathy. Am Heart J 130 (1995) 860-870
41. van Hoeven K.H., Kitsis R.N., Katz S.D., and Factor S.M. Peripartum versus idiopathic dilated cardiomyopathy in young women-a comparison of clinical pathologic, and prognostic features. Int J Cardiol 40 (1993) 57-65
42. Pierce J.A., Price B.O., and Joyce J.W. Familial occurrence of postpartal heart failure. Arch Intern Med 111 (1963) 651-655
43. Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J 129 (1995) 421-422
44. Massad L.S., Reiss C.K., Mutch D.G., and Hasket E.J. Family peripartum cardiomyopathy after molar pregnancy. Obstet Gynecol 81 (1993) 886-888
45. Farber P.A., and Glasgow L.A. Viral myocarditis during pregnancy: encephalomyocarditisvirus infection in mice. Am Heart J 80 (1970) 96-102
46. Lyden D.C., and Huber S.A. Aggravation of coxsackie virus, group B, type-3-induced myocarditis and increase in cellular immunity to myocyte antigens in pregnant Balb/c mice and animal treated with progesterone. Cell Immunol 87 (1984) 462-472
47. Kovithavongs T., and Dossetor J.B. Suppressor cells in human pregnancy. Transplant Proc 10 (1978) 911-913
48. Thong Y.H., Steele R.W., Vincent M.M., Hensen S.A., and Bellanti J.A. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy. N Engl J Med 289 (1973) 604-606
49. D'Cruz I.A., Balani S.G., and Iyer L.S. Infectious hepatitis and pregnancy. Obstet Gynecol 31 (1968) 449-455
50. Sanderson J.E., Olsen E.G., and Gatei D. Peripartum heart disease: an endomyocardial biopsy study. Br Heart J 56 (1986) 285-291
51. Midei M.G., DeMent S.H., Feldman A.M., Hutchins G.M., and Baughman K.L. Peripartum myocarditis and cardiomyopathy. Circulation 81 (1990) 922-928
52. Melvin K.R., Richardson P.J., Olsen E.G., Daly K., and Jackson G. Peripartum cardiomyopathy due to myocarditis. N Engl J Med 307 (1982) 731-734
53. Felker G.M., Jaeger C.J., Klodas E., et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J 140 (2000) 785-791
54. Chow L.H., Radio S.H., Sears T.D., and McManus B.M. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 14 (1989) 915-920
55. Hauck A.J., Kearney D.L., and Edwards W.D. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for the role of sampling error. Mayo Clin Proc 64 (1989) 1235-1245
56. Ansari A.A., Neckelmann N., Wang Y.C., Gravanis M.B., Sell K.W., and Herskowitz A. Immunologic dialogue between cardiac myocytes, endothelial cells and mononuclear cells. Clin Immunol Immunopathol 68 (1993) 208-214
57. Sliwa K., Skudicky D., Bergemann A., Candy G., Puren A., and Sareli P. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am Coll Cardiol 35 (2000) 701-705
58. Sliwa, K., Forster, O., Libhaber, E., Fett, J.D., Sundstrom, J.B., Hilfiker-Kleiner, D., Ansari, A.A. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur Heart J. 2005 Sep 5; [Epub ahead of print].
59. Klintschar M., Schwaiger P., Mannweiler S., Regauer S., and Kleiber M. Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab 86 (2001) 2494-2498
60. Miyashita Y., Ono M., Ono M., Ueki H., and Kurasawa K. Y chromosome microchimerism in rheumatic autoimmune disease. Ann Rheum Dis 59 (2000) 655-656
61. Johnson K.L., Nelson J.L., and Furst D.E. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis. Arthritis Rheum 44 (2001) 1848-1854
62. Ansari A.A., Fett J.D., Carraway R.E., Mayne A.E., Onlamoon N., and Sundstrom J.B. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clin Rev Allergy Immunol 23 (2002) 301-324
63. Sundstrom J.B., Fett J.D., Carraway R.D., and Ansari A.A. Is peripartum cardiomyopathy an organ-specific autoimmune disease?. Autoimmun Rev 1 (2002) 73-77
64. Warraich R.S., Sliwa K., Damasceno A., et al. Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. Am Heart J 150 (2005) 263-269
65. Warraich R.S., Young J.B., Sestier F., et al. Clinical and prognostic relevance of Ig-G3 reactivity in heart failure: a substudy of vasogen's immune modulation therapy in patients with chronic heart failure. J Am Coll Cardiol 43 (2004) 226A
66. Knobel B., Melamud E., and Kishon Y. Peripartum cardiomyopathy. Isr J Med Sci 20 (1984) 1061-1063
67. Liu Y., Cigola E., Cheng W., et al. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 73 (1995) 771-787
68. Sharov V.G., Sabbah H.N., Shimoyama H., Goussev A.V., Lesch M., and Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 148 (1996) 141-149
69. Li Z., Bing O.H., Long X., Robinson K.G., and Lakatta E.G. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 272 (1997) H2313-H2319
70. Adams J.W., Sakata Y., Davis M.G., et al. Enhanced Gαq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A 95 (1998) 10140-10145
71. Hirota H., Chen J., Betz U.A., et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97 (1999) 189-198
72. Condorelli G., Morisco C., Stassi G., et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99 (1999) 3071-3078
73. Geng Y.J., Ishikawa Y., Vatner D.E., et al. Apoptosis of cardiac myocytes in Gs transgenic mice. Circ Res 84 (1999) 34-42
74. Zhang D., Gaussin V., Taffet G.E., et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 6 (2000) 556-563
75. Xing H., Zhang S., Weinheimer C., Kovacs A., and Muslin A.J. 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J 19 (2000) 349-358
76. Bisognano J.D., Weinberger H.D., Bohlmeyer T.J., et al. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. J Mol Cell Cardiol 32 (2000) 817-830
77. Sam F., Sawyer D.B., Chang D.L., et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol 279 (2000) H422-H428
78. Palojoki E., Saraste A., Eriksson A., et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol 280 (2001) H2726-H2731
79. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335 (1996) 1182-1189
80. Olivetti G., Abbi R., Quaini F., et al. Apoptosis in the failing human heart. N Engl J Med 336 (1997) 1131-1141
81. Saraste A., Pulkki K., Kallajoki M., et al. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29 (1999) 380-386
82. Guerra S., Leri A., Wang X., et al. Myocyte death in the failing human heart is gender dependent. Circ Res 85 (1999) 856-866
83. Haider N., Narula N., and Narula J. Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling. J Card Fail 8 (2002) 512-517
84. Nadal-Ginard B., Kajstura J., Leri A., and Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 92 (2003) 139-150
85. Dorn II G.W., and Brown J.H. Gq signaling in cardiac adaptation and maladaptation. Trends Cardiovasc Med 9 (1999) 26-34
86. D'Angelo D.D., Sakata Y., Lorenz J.N., et al. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A 94 (1997) 8121-8126
87. Sakata Y., Hoit B.D., Liggett S.B., Walsh R.A., and Dorn II G.W. Decompensation of pressure-overload hypertrophy in Gq-overexpressing mice. Circulation 97 (1998) 1488-1495
88. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
89. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
90. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
91. Jeremias I., Kupatt C., Martin-Villalba A., et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 102 (2000) 915-920
92. Lee P., Sata M., Lefer D.J., Factor S.M., Walsh K., and Kitsis R.N. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol 284 (2003) H456-H463
93. Bialik S., Cryns V.L., Drincic A., et al. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res 85 (1999) 403-414
94. Malhotra R., and Brosius III F.C. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem 274 (1999) 12567-12575
95. von Harsdorf R., Li P.F., and Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99 (1999) 2934-2941
96. de Moissac D., Gurevich R.M., Zheng H., Singal P.K., and Kirshenbaum L.A. Caspase activation and mitochondrial cytochrome c release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 32 (2000) 53-63
97. Kang P.M., Haunstetter A., Aoki H., Usheva A., and Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res 87 (2000) 118-125
98. Adams J.W., Pagel A.L., Means C.K., Oksenberg D., Armstrong R.C., and Brown J.H. Cardiomyocyte apoptosis induced by Gq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ Res 87 (2000) 1180-1187
99. Yussman M.G., Toyokawa T., Odley A., et al. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 8 (2002) 725-730
100. Hayakawa Y., Chandra M., Miao W., et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Gαq transgenic mice. Circulation 108 (2003) 3036-3041
101. Murphy J.G. Peripartum cardiomyopathy. In: Cooper L.T. (Ed). Myocarditis: from bench to bedside (2003), Humana Press, Totowa (NJ) 589-608
102. Bultmann B.D., Klingel K., Nabauer M., Wallwiener D., and Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193 (2005) 363-365
103. Bachmaier K., Neu N., de la Maza L.M., Pal S., Hessel A., and Penninger J.M. Chlamydia infections and heart disease linked through antigenic mimicry. Science 283 (1999) 1335-1339
104. Cenac A., Djibo A., Sueur J.M., Chaigneau C., and Orfila J. Chlamydia infection and peripartum dilated cardiomyopathy in Niger. Med Trop (Mars) 60 (2000) 137-140
105. Cenac A., Djibo A., Chaigneau C., Velmans N., and Orfila J. Are anti-Chlamydia pneumoniae antibodies prognosis indicators for peripartum cardiomyopathy?. J Cardiovasc Risk 10 (2003) 195-199
106. Arnould N., Diemunsch P., Raiga J., and Brettes J.P. Peripartum dilated cardiomyopathies: is there a correlation with sexually transmitted diseases?. Gynecol Obstet Fertil 30 (2002) 59-63
107. Walsh J.J., Burch G.E., Black W.C., Ferrans V.J., and Hibbs R.G. Idiopathic myocardiopathy of the puerperium (postpartal heart disease). Circulation 32 (1965) 19-31
108. Seftel H., and Susser M. Maternity and myocardial failure in African women. Br Heart J 23 (1961) 43-52
109. Kothari S.S. Aetiopathogenesis of peripartum cardiomyopathy: prolactin-selenium interaction?. Int J Cardiol 60 (1977) 111
110. Blegen S.D. Post-partum congestive heart failure. Beri-beri heart disease. Acta Med Scand 178 (1965) 515-524
111. Fett J.D., Ansari A.A., Sundstrom J.B., and Combs G.F. Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. Int J Cardiol 86 (2002) 311-316
112. Costanzo-Nordin M.R., and O'Connell J.B. Peripartum cardiomyopathy in the 1990's etiologic and prognostic considerations and review of the literature. In: Zipes D.P., and Rowlands D.J. (Eds). Progress in cardiology (1989), Lea and Febiger, Philadelphia, PA 225-239
113. Stamler J., Horowitz S.F., Goldman M.E., Matza D., and Machac J. Peripartum cardiomyopathy: a role for cardiac stress determinants other than pregnancy?. Mt Sinai J Med 56 (1989) 285-289
114. Brockington I.F. Postpartum hypertensive heart failure. Am J Cardiol 27 (1971) 650-658
115. Phillips Jr. J.H., and Burch G.E. A review of cardiovascular diseases in the White and Negro races. Medicine 39 (1960) 241-288 (Baltimore)
116. Adesanya C.O. Peripartum heart failure-a reappraisal of the concept. In: Akinkugbe O.O. (Ed). Cardiovascular disease in Africa (1976), Ciba-Geigy, Ikega, Nigeria 325
117. Brown C.S., and Bertolet B.D. Peripartum cardiomyopathy: a comprehensive review. Am J Obstet Gynecol 178 (1998) 409-414
118. Rahimtoola S.H., and Tak T. The use of digitalis in heart failure. Curr Probl Cardiol 21 (1996) 781-853
119. Mastrobattisha J.M. Angiotensin converting enzyme inhibitors in pregnancy. Semin Perinatol 21 (1997) 124-134
120. Packer M., O'Connor C.M., Ghali J.K., et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 335 (1996) 1107-1114
121. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
122. Lip A.Y.H., Beevers M., Churchill D., Shaffer L.M., and Beevers D.G. Effect of atenolol on birth weight. Am J Cardiol 79 (1997) 1436-1438
123. Stempel J.E., O'Grady J.P., Morton M.J., and Johnson K.A. Use of sodium nitroprusside in complications of gestational hypertension. Obstet Gynecol 60 (1982) 533-538
124. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333 (1995) 269-275
125. Box L.C., Hanak V., and Arciniegas J.G. Dual coronary emboli in peripartum cardiomyopathy. Tex Heart Inst J 31 (2004) 442-444
126. Nishi I., Ishimitsu T., Ishizu T., et al. Peripartum cardiomyopathy and biventricular thrombi. Circ J 66 (2002) 863-865
127. Damorou F.J., Kane A., Napporn G., et al. Biventricular thrombus complicating peripartum cardiomyopathy. A case report. Dakar Med 45 (2000) 199-201
128. Sanchez-Rubio Lezcano J., Galache Osuna J.G., Marquina Barcos A., Calvo Cebollero I., Diarte de Miguel J.A., and Placer Peralta L.J. Peripartum cardiomyopathy with biventricular thrombi. Ann Med Intern 21 (2004) 498-500
129. Quinn B., Doyle B., and McInerney J. Postnatal pre-cordial pain. Pulmonary embolism or peripartum cardiomyopathy. Emerg Med J 21 (2004) 746-747
130. Bennani S.L., Loubaris M., and Lahlou I. Postpartum cardiomyopathy revealed by acute lower limb ischemia. Ann Cardiol Angeiol 52 (2003) 382-385 (Paris)
131. Kaufman I., Bondy R., and Benjamin A. Peripartum cardiomyopathy and thromboembolism; anesthetic management and clinical course of an obese, diabetic patient. Can J Anaesth 50 (2003) 161-165
132. Pettifor J.M., and Benson R. Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 86 (1975) 459-462
133. Aravot D.J., Banner N.R., Dhalla N., et al. Heart transplantation for peripartum cardiomyopathy. Lancet 2 (1987) 1024
134. Keogh A., Macdonald P., Spratt P., Marshman D., Larbalestier R., and Kaan A. Outcome in peripartum cardiomyopathy after heart transplantation. J Heart Lung Transplant 13 (1994) 202-207
135. Rickenbacher P.R., Rizeq M.N., Hunt S.A., Billingham M.E., and Fowler M.B. Long-term outcome after heart transplantation for peripartum cardiomyopathy. Am Heart J 127 (1994) 1318-1323
136. Kereiakes D.J., and Parmley W.W. Myocarditis and cardiomyopathy. Am Heart J 108 (1984) 1318-1326
137. Dec Jr. G.W., Palacios I.F., Fallon J.T., et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312 (1985) 885-890
138. Drucker N.A., Colan S.D., Lewis A.B., et al. Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89 (1994) 252-257
139. Bozkurt B., Villaneuva F.S., Holubkov R., et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol 34 (1999) 177-180
140. Sutton M.S., Cole P., Plappert M., Saltzman D., and Goldhaber S. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J 121 (1991) 1776-1778
141. Dorbala S., Brozena S., Zeb S., et al. Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. J Am Soc Echocardiogr 18 (2005) 45-48
142. Lampert M.B., Weinert L., Hibbard J., Korcarz C., Lindheimer M., and Lang R.M. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. Am J Obstet Gynecol 176 (1997) 189-195
143. Elkayam U., Tummala P.P., Rao K., et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 344 (2001) 1567-1571
144. Avila W.S., de Carvalho M.E., Tschaen C.K., et al. Pregnancy and peripartum cardiomyopathy. A comparative and prospective study. Arq Bras Cardiol 79 (2002) 484-493